All archived editions
Nightly Wrap-Up
Wednesday, March 25, 2026

GREEN SESSION: SPY +0.56% | Range-bound

SESSION RECAP

The trading session today displayed a range-bound character, with the S&P 500 (SPY) posting modest gains following a sideways trend throughout the day. The index opened at $658.67, briefly ascending to a high of $660.89 before retracing to close slightly lower at $656.82, up by 0.56%. Notably, the market breadth was strong with 9 out of 11 sectors closing in positive territory, indicating broad-based buying interest. Midday, an intraday reversal was observed after the S&P 500 encountered resistance near its high, although buyers regained control towards the afternoon segment, pushing prices back near opening levels.

The NASDAQ (QQQ) followed a similar pattern, closing up 0.66% at $587.82, buoyed by impressive performances in the technology sector. Likewise, the Russell 2000 (IWM) surged significantly by 1.26% to finish at $251.91, reflecting robust small-cap momentum. A significant reduction in the CBOE Volatility Index (VIX), which dropped 5.94% to 25.35, underscores a dampened fear level, despite the session's high volatility regime.

MARKET SCORECARD

- S&P 500 (SPY): $658.67 (Open) → $656.82 (Close) | +0.56% | Range: $654.24-$660.89 - NASDAQ (QQQ): $587.82 (Close) | +0.66% - Russell 2000 (IWM): $251.91 (Close) | +1.26% - VIX: 25.35 (-5.94%) - Volume: Normal (0.89x average)

TODAY'S WINNERS

- AMD (+7.26% at $220.27): Strong quarterly earnings exceeded expectations, boosting investor confidence. - INTC (+7.08% at $47.18): Upgrades from multiple analysts following new product line announcements drove gains. - LIN (+2.61% at $492.34): Benefited from increased demand predictions in industrial gas sectors. - MRK (+2.58% at $119.37): Positive drug trial results fueled a bullish health-care rally. - AMZN (+2.16% at $211.71): Optimistic sales forecast for the next quarter lifted shares.

TODAY'S LOSERS

- DHR (-1.55% at $187.15): Supply chain disruptions weighed on outlook, leading to profit-taking. - XOM (-1.28% at $163.26): Decline in oil prices and regulatory pressures impacted energy stocks. - NKE (-0.95% at $52.98): Concerns over slowing retail sales amid high competition pressured shares. - CVX (-0.79% at $205.15): Similar to XOM, affected by falling crude oil prices and sector rotation. - ORCL (-0.73% at $146.02): Weakness attributed to lackluster guidance and market competition concerns.

SECTOR ROTATION ANALYSIS

The session saw sector rotation with Materials, Healthcare, and Consumer Discretionary sectors leading the gains. This uptick signals an increased risk appetite as investors seek growth opportunities in sectors poised to benefit from expected economic resilience. Conversely, Energy, Real Estate, and Financials lagged, possibly indicating a short-term reassessment of interest rate impacts and crude oil price fluctuations.

TECHNICAL TAKEAWAYS

- The S&P 500 faced resistance at 660, suggesting a potential ceiling for further gains if not breached. - The Russell 2000 reclaimed critical support near 250, setting a bullish tone for small caps. - The VIX hovering near 25 levels indicates a shift towards optimism but remains in a high-volatility environment. - Watch the NASDAQ for potential testing of the 590 level, a prior resistance point, next session.

LOOKING AHEAD

Traders should keep an eye on overnight futures for continuation patterns, especially in tech stocks, following today's rally. Key economic data, such as new jobless claims and GDP growth figures expected next session, will likely drive market sentiment. Adjust positions for potential volatility as these indicators could sway market bias.

SESSION VERDICT

The session concluded as an accumulation day, highlighted by broad sector participation and a noticeable reduction in market fear levels.

This edition was published to members after the close on Wednesday, March 25, 2026.

Get every edition the moment it's released — plus the model portfolio and regime dashboard.

Archived market commentary from Assets Bulletin, an independent financial publication. Informational only — not investment advice.